GALECTIN THERAPEUTICS INC — Director's Dealing 2014

Jan 13, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GALECTIN THERAPEUTICS INC (GALT)
CIK: 0001133416
Period of Report: 2014-01-10

Reporting Person: Shlevin Harold H. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-10	Common Stock	M	50000	$2.32	Acquired	103914	Direct
2014-01-10	Common Stock	F	8598	$13.491	Disposed	95316	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-01-10	Stock Options	$2.32	M	50000	Disposed	2022-08-27	Common Stock (50000)	Direct

Footnotes

F1: Stock options vest as follows: 50,000 shares vested on August 27, 2012, 50,000 shares vested on December 31, 2012, 75,000 shares vested on December 31, 2013 and 75,000 shares will vest on December 31, 2014.